Spectrum Pharrmaceuticals

FDA panel votes against Spectrum's lung cancer drug
Reuters
Thu, 09/22/22 - 11:54 pm
FDA
Spectrum Pharrmaceuticals
non-small cell lung cancer
poziotinib
ESMO 2021 movers – a handful of biotech winners emerge
EP Vantage
Fri, 09/24/21 - 11:48 am
ESMO
Corbus Pharmaceuticals
Leap Therapeutics
Surface Oncology
AstraZeneca
Innate Pharma
Immunocore
Daiichi Sankyo
Verastem
Spectrum Pharrmaceuticals
Mirati Therapeutics